跳至主要内容
临床试验/NCT06482125
NCT06482125已完成不适用

Emergence Agitation in Pediatrics After Dexmedetomidine vs. Sevoflurane Anesthesia: a Randomized Controlled Trial

Pelita Harapan University1 个研究点 分布在 1 个国家目标入组 121 人开始时间: 2024年7月31日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
121
试验地点
1
主要终点
Emergence Agitation

研究概览

简要总结

Emergence agitation is commonly encountered after receiving inhalation anesthesia. This distressing phenomenon carries risks that are harmful to patients, caregivers and medical personnel. Using total intravenous Dexmedetomidine, the investigators seek to reduce agitation and provide gentle emergence from anesthesia.

详细描述

Surgery for pediatric cleft lip and palate repair often utilizes high dose opioids and inhaled anaesthesia, thereby causing postoperative complications such as desaturation and/or severe agitation after anesthesia. These complications are detrimental to the child, medical personnel and causes tremendous psychologic stress to parents. This study aims to decrease these complications through Dexmedetomidine, an Alpha-2 receptor agonist with anxiolytic, sympatholytic and analgetic properties. Devoid of respiratory depressant effect, it allows patients to maintain effective ventilation and reduce agitation, postoperatively. Its unique anesthetic property may shed light to provide safe anesthesia and gentle emergence to this young, vulnerable population.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

盲法说明

Patients are selected randomly using a computer-generated device to become a control arm or a treatment arm

入排标准

年龄范围
3 Months 至 10 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Patients with weight ranging 5 kg - 25 kg
  • Patients with American Society of Anesthesiologist (ASA) Physical Status Classification 1 and 2

排除标准

  • Patients with any acquired congenital syndrome
  • Patients who are actively taking anti-seizure medications and/or has been diagnosed with epilepsy
  • Patients with functional and structural abnormalities of the heart, including arrythmias
  • Patients with liver disease

研究组 & 干预措施

Inhalation Sevoflurane

Active Comparator

Participants in this group will receive inhalation anesthesia Sevoflurane at 2-3 Vol% as their sole anesthetic maintenance agent throughout the surgical procedure.

干预措施: Sevoflurane (Drug)

Total Intravenous Dexmedetomidine

Experimental

Participants in this group will receive Total Intravenous Dexmedetomidine as their sole anesthetic maintenance agent. Intravenous Dexmedetomidine 1.5ug/kg will be administered within 10 minutes and maintenance dose of 1.5ug/kg/hour will be given throughout the surgical procedure.

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

Emergence Agitation

时间窗: Assessed starting the time of extubation and every 15 minutes interval until the patient is completely awake in the recovery room. The average of all values throughout the observation period was summed and the average scale reported.

Cravero scale uses a numeric scale. 1 = obtunded with no response to stimulation; 2 = asleep, but responsive to movement or stimuli; 3 = awake and responsive, 4 = crying; 5 = thrashing behavior that requires restraint. Minimum values of NOT AGITATED is 1.0 up to maximum of 2.9. Minimum values of AGITATED is 3.10 up to maximum of 5.0. Cravero scale is measured from the moment of extubation and every 15 minutes thereafter until the patient is completely awakened (in the recovery room). The total score is summed, and the average is reported.

Duration of Anesthesia (Minutes)

时间窗: From time of anesthesia induction up to the termination of anesthetic agent, assessed up to two hours.

Measures the time of anesthesia (in minutes) starting from induction of anesthesia to the termination of anesthetic agent

Duration of Surgery (Minutes)

时间窗: From time of surgery up to the termination of anesthetic agent, assessed up to two hours.

Measures the time of surgery after the application of sterile draping up to the end of surgery.

次要结局

  • Time to Extubation (Minutes)(Maximum time to extubate was up to 26 minutes.)
  • Time to Full Recovery(Maximum time observed was up to 105 minutes.)

研究者

发起方
Pelita Harapan University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Corry Quando Yahya

Pediatric Anesthesiologist and Lecturer at Pelita Harapan University, Department of Anesthesia and Intensive Care

Pelita Harapan University

研究点 (1)

Loading locations...

相似试验

Emergence Agitation Between Dexmedetomidine and... | 临床试验